SAB Biotherapeutics (SABS) Stock Chart & Stock Price History $1.76 0.00 (0.00%) As of 01:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SAB Biotherapeutics Stock Price Performance The SAB Biotherapeutics (SABS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 42.27%, with a year-to-date return of -53.69%. In the past month, the stock has decreased 6.15%, reflecting recent market activity. As of the latest close, SAB Biotherapeutics traded at $1.76 with a market cap of $16.30 million and volume of 14,746 shares. Receive SABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.40%1 Month Performance-6.15%3 Month Performance+46.25%Year-To-Date Performance-53.69%1 Year Performance-42.27% SABS Stock Chart for Tuesday, July, 1, 2025 SABS Chart by TradingView SAB Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$1.69$1.76+3.85%$1.79$1.6714,746 shs$16.30 million06/27/2025$1.78$1.69-5.06%$1.85$1.6918,811 shs$15.70 million06/26/2025$1.78$1.78$1.87$1.779,113 shs$16.54 million06/25/2025$1.80$1.78-1.11%$1.85$1.732,633 shs$16.53 million06/24/2025$1.76$1.80+2.27%$1.80$1.724,550 shs$16.72 million06/23/2025$1.79$1.76-1.68%$1.82$1.728,128 shs$16.35 million06/20/2025$1.78$1.79+0.56%$1.79$1.7211,931 shs$16.63 million06/19/2025$1.78$1.78$1.80$1.678,148 shs$16.54 million06/18/2025$1.78$1.78$1.80$1.678,148 shs$16.54 million06/17/2025$1.70$1.78+4.71%$1.79$1.657,116 shs$16.53 million Get the Latest News and Ratings for SABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$1.71$1.70-0.58%$1.77$1.6512,681 shs$15.79 million06/13/2025$1.83$1.71-6.61%$1.85$1.6054,620 shs$15.88 million06/12/2025$1.88$1.83-2.61%$1.89$1.7355,088 shs$17.01 million06/11/2025$1.87$1.88+0.53%$1.88$1.8213,045 shs$17.46 million06/10/2025$1.86$1.87+0.54%$1.89$1.799,800 shs$17.37 million06/09/2025$1.81$1.86+2.76%$1.88$1.799,342 shs$17.28 million06/06/2025$1.82$1.81-0.55%$1.92$1.802,411 shs$16.82 million06/05/2025$1.87$1.82-2.54%$1.92$1.832,930 shs$16.91 million06/04/2025$1.86$1.87+0.40%$1.88$1.7618,280 shs$17.35 million06/03/2025$1.92$1.86-3.12%$1.92$1.8410,363 shs$17.28 million06/02/2025$1.87$1.92+2.67%$1.96$1.8232,906 shs$17.84 million05/30/2025$1.81$1.87+3.31%$2.00$1.8059,305 shs$17.38 million Related Companies FBIO Stock Chart CRIS Stock Chart BOLT Stock Chart CBIO Stock Chart MTEM Stock Chart AMGN Stock Chart GILD Stock Chart VRTX Stock Chart REGN Stock Chart ALNY Stock Chart Receive SABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SABS) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredFine. Don’t believe me. They called me an alarmist... When in 2010 I said America’s debt was out of control. When I warned it w...Porter & Company | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SAB Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SAB Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SABS Stock Alerts